Mylène Perreault

机构：Synlogic (United States) · ORCID：0000-0002-3644-6413

发表论文 47 篇 · 总被引 3024 次 · h-index 24

代表论文

An engineered E. coli Nissle improves hyperammonemia and survival in mice and shows dose-dependent exposure in healthy humans (2019 · Science Translational Medicine · 被引 398)
Targeting Acyl-CoA:Diacylglycerol Acyltransferase 1 (DGAT1) with Small Molecule Inhibitors for the Treatment of Metabolic Diseases (2011 · Journal of Biological Chemistry · 被引 157)
Mice deleted for GPAT3 have reduced GPAT activity in white adipose tissue and altered energy and cholesterol homeostasis in diet-induced obesity (2014 · American Journal of Physiology-Endocrinology and Metabolism · 被引 57)
An engineered bacterial therapeutic lowers urinary oxalate in preclinical models and in silico simulations of enteric hyperoxaluria (2022 · Molecular Systems Biology · 被引 49)
Profiling Serum Bile Acid Glucuronides in Humans: Gender Divergences, Genetic Determinants, and Response to Fenofibrate (2013 · Clinical Pharmacology & Therapeutics · 被引 48)
Engineered bacteria producing aryl‐hydrocarbon receptor agonists protect against ethanol‐induced liver disease in mice (2023 · Alcoholism Clinical and Experimental Research · 被引 35)